HKSH proton therapy shows 100% breast cancer survival
July 08, 2026 | 10:45
HKSH's first-in-Asia comparative study found hypofractionated proton therapy prevented breast cancer recurrence with a 100 per cent survival rate, minimising cardiopulmonary risks and maintaining quality of life.
Mobile Version